2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Personality Dynamics and Cognitive Impairment and Related Neuropsychiatric Symptoms in Patience with Different Movement Disorders

M. Kulsum, M. Naaz, A. Das, A. Das, T. Dolai, S. Majumdar (Kolkata, India)
Personalized Factors Influencing Technological Solutions for Mobility – Insights from A Wearable Device in Parkinsons Disease

A. Desai, R. Rajput (Mumbai, India)
Personalized Rhythmic Cueing Differentially Improves Straight Walking and Turning in Parkinson’s Disease

CY. Chien, YH. Liu, YL. Chen, CL. Lin, JSK. Chang, CCK. Lin (Tainan, Taiwan)
PEST-PD: Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides.

E. Cubo, L. Gomez-Cuadrado, D. Garcia-Garcia, A. Canepa, B. Alonzo-Nuñez, D. de Lara (Burgos, Spain)
Pesticide Exposure and Motor Severity in Parkinson’s Disease in a Mexican Population: A Retrospective Longitudinal Cohort Study

J. Espinoza-Solares, A. Tapia, L. Cortés, J. López-Moreno, A. Cervantes-Arriaga, M. Rodriguez-Violante (Ciudad de México, Mexico)
Pesticide Exposure and Smoking in Parkinson’s Disease in Kyrgyzstan: A Case–Control Study

A. Kubanychbekova, A. Ismailova, E. Zhunusova, S. Kyialbekova, A. Abdumalikova, C. Shambetova (Bishkek, Kyrgyzstan)
PET Imaging of Presynaptic Terminals with [18F]SynVesT-1 in Premanifest Huntington’s Disease

J. van Opstal, G. Vanderlinden, A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)
Pharmacogenomic Analysis of KM-819-Related Hepatotoxicity in Patients with Multiple System Atrophy

J. Han, R. Andrade, ES. Björnsson, JH. Lewis, MI. Lucena, S. Go, S. Stankeviciute, G. Aithal, G. Kim, C. Lee, C. Barlow, E. Kim (Bundang-gu, Republic of Korea)
Pharmacoscintigraphic Evaluation and Safety of a Novel, Dual-pulse, Delayed-release carbidopa/levodopa Tablet for Bedtime Dosing

A. østerskov, A. Elvang, T. Sager, K. Christensen, F. Macdougall, L. Corry (Horsholm, Denmark)
Phase 1 Study of BT-267, a potent, selective, brain-penetrant, and oral small molecule inhibitor of LRRK2

T. Dam, D. Hilt, E. Remeeva, A. Mathias, M. Mcgill, K. Dokukina, A. Pushechnikov, R. Karapetyan, V. Kazey, I. Dukes, N. Savchuk (Dover, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z